Endometrial cancer is the most commonly diagnosed cancer of the female reproductive tract
in developed countries. Through genome-wide association studies (GWAS), we have …

Breast cancer is a heterogeneous disease with distinct molecular subtypes including the
aggressive subtype triple-negative breast cancer (TNBC). We compared blood-borne miRNA …

Purpose BRCA1/2 mutations are frequent in patients with triple-negative breast cancer (TNBC).
These patients are often treated with primary systemic chemotherapy. The aim of this …

PURPOSE Among patients with metastatic breast cancer (mBC), the frequency of germline
mutations in cancer susceptibility genes and the clinical relevance of these mutations are …

Background: The strongest known risk factor for endometrial cancer is obesity. To determine
whether SNPs associated with increased body mass index (BMI) or waist–hip ratio (WHR) …

Epidemiological, biological, and molecular data suggest links between endometriosis and
endometrial cancer, with recent epidemiological studies providing evidence for an association …

Blood lipids have been associated with the development of a range of cancers, including
breast, lung and colorectal cancer. For endometrial cancer, observational studies have …

This study examines the development of aluminium–aluminium compounds during high
pressure die casting. An aluminium insert was mounted into a die casting mould and embedded …

Background: Despite advancements in the treatment of primary and metastatic breast cancer,
many patients lack a durable response to these treatments. Patients with triplenegative …

Background Pembrolizumab is approved for the neoadjuvant/adjuvant treatment of early
triple-negative breast cancer (TNBC) patients in combination with chemotherapy. The Keynote-…